I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Parli, Teresa
23
results:
Search for persons
X
Format
Online (23)
Mediatypes
Articles (Online) (10)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Author Correction: The FGF21 analog pegozafermin in severe ..:
Bhatt, Deepak L.
;
Bays, Harold E.
;
Miller, Michael
...
Nature Medicine. 30 (2024) 6 - p. 1788-1789 , 2024
Link:
https://doi.org/10.1038/..
?
2
Study Design of a Phase 3 Randomized Controlled Trial Evalu..:
Hartsfield, Cynthia
;
Bhatt, Deepak
;
Bays, Harold
...
Journal of Clinical Lipidology. 18 (2024) 4 - p. e552-e553 , 2024
Link:
https://doi.org/10.1016/..
?
3
The FGF21 analog pegozafermin in severe hypertriglyceridemi..:
Bhatt, Deepak L.
;
Bays, Harold E.
;
Miller, Michael
...
Nature Medicine. 29 (2023) 7 - p. 1782-1792 , 2023
Link:
https://doi.org/10.1038/..
?
4
Pegozafermin for the Treatment of Severe Hypertriglyceridem..:
Bhatt, Deepak L.
;
Bays, Harold E.
;
Miller, Michael
...
Metabolism. 142 (2023) - p. 155456 , 2023
Link:
https://doi.org/10.1016/..
?
5
† Pegozafermin for the Treatment of Severe Hypertriglycerid..:
Bhatt, Deepak L
;
Hartsfield, Cynthia L
;
Bays, Harold E
...
Journal of Clinical Lipidology. 17 (2023) 4 - p. e47-e48 , 2023
Link:
https://doi.org/10.1016/..
?
6
Prevalence of Nonalcoholic Fatty Liver Disease in Patients ..:
Bhatt, Deepak L.
;
Kastelein, John J.P.
;
Parli, Teresa
...
Metabolism. 128 (2022) - p. 155012 , 2022
Link:
https://doi.org/10.1016/..
?
7
Five-year Survival Prediction and Safety Outcomes with Enza..:
Armstrong, Andrew J.
;
Lin, Ping
;
Tombal, Bertrand
...
European Urology. 78 (2020) 3 - p. 347-357 , 2020
Link:
https://doi.org/10.1016/..
?
8
Prognostic Association of Prostate-specific Antigen Decline..:
Armstrong, Andrew J.
;
Lin, Ping
;
Higano, Celestia S.
...
European Urology Oncology. 2 (2019) 6 - p. 677-684 , 2019
Link:
https://doi.org/10.1016/..
?
9
Enzalutamide in Men with Chemotherapy-naïve Metastatic Cast..:
Beer, Tomasz M.
;
Armstrong, Andrew J.
;
Rathkopf, Dana
...
European Urology. 71 (2017) 2 - p. 151-154 , 2017
Link:
https://doi.org/10.1016/..
?
10
Health-related quality of life effects of enzalutamide in p..:
Devlin, Nancy
;
Herdman, Michael
;
Pavesi, Marco
...
Health and Quality of Life Outcomes. 15 (2017) 1 - p. , 2017
Link:
https://doi.org/10.1186/..
?
11
The FGF21 analog pegozafermin in severe hypertriglyceridemi..:
Bhatt, Deepak L
;
Bays, Harold E
;
Miller, Michael
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353930/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
The FGF21 analog pegozafermin in severe hypertriglyceridemi..:
Bhatt, Deepak
;
Bays, Harold E
;
Miller, Michael
...
https://repository.publisso.de/resource/frl:6453167. , 2023
Link:
https://repository.publi..
?
13
Five-year Survival Prediction and Safety Outcomes with Enza..:
Armstrong, Andrew J
;
Lin, Ping
;
Tombal, Bertrand
...
info:eu-repo/grantAgreement/Pfizer Inc (NY)//. , 2020
Link:
http://hdl.handle.net/20..
?
14
Five-year Survival Prediction and Safety Outcomes with Enza..:
Armstrong, Andrew J
;
Lin, Ping
;
Tombal, Bertrand
...
info:eu-repo/grantAgreement/Pfizer Inc (NY)//. , 2020
Link:
http://hdl.handle.net/20..
?
15
Association Between New Unconfirmed Bone Lesions and Outcom..:
Armstrong, Andrew J
;
Al-Adhami, Mohammed
;
Lin, Ping
...
info:eu-repo/grantAgreement/Pfizer Inc (New York, New York)//. , 2020
Link:
http://hdl.handle.net/20..
1-15